|
Volumn 5, Issue 4, 2000, Pages 222-226
|
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLARITHROMYCIN;
OMEPRAZOLE;
RANITIDINE BISMUTH CITRATE;
ADULT;
AGED;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL STRAIN;
BACTERIUM CULTURE;
BACTERIUM ISOLATE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
DRUG POTENTIATION;
ERADICATION THERAPY;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
BISMUTH;
CLARITHROMYCIN;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE, MICROBIAL;
DRUG SYNERGISM;
DUODENAL ULCER;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
OMEPRAZOLE;
RANITIDINE;
BACTERIA (MICROORGANISMS);
HELICOBACTER;
HELICOBACTER PYLORI;
|
EID: 0034583856
PISSN: 10834389
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1523-5378.2000.00034.x Document Type: Article |
Times cited : (31)
|
References (27)
|